Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research
Metabolic dysfunction-associated steatohepatitis (MASLD) is a liver disease with complex pathogenesis, characterized by abnormal lipid accumulation within hepatocytes, inflammation, and fibrosis. Its increasing incidence in recent years constitutes a serious…
